Meloxicam Ciclum

Meloxicam, the active ingredient in Meloxicam Ciclum, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and other acute musculoskeletal conditions.

GNH USA supplies Meloxicam Ciclum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Meloxicam acts on inflammatory pathways in musculoskeletal disorders, providing analgesic and anti‑inflammatory effects.

- Osteoarthritis: reduces joint pain and swelling, improving mobility. - Rheumatoid arthritis: alleviates chronic inflammation and joint damage progression. - Ankylosing spondylitis: diminishes spinal pain and stiffness. - Acute pain: provides rapid relief of moderate to severe pain from injuries or postoperative states.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Cardiovascular thrombotic events (e.g., heart attack, stroke) - Severe skin reactions such as Stevens‑Johnson syndrome - Acute renal impairment or failure

Before initiating meloxicam therapy, consider the following precautions to minimize risk. - Cardiovascular risk assessment: evaluate history of heart disease or stroke before use. - Renal function monitoring: check kidney function periodically, especially in elderly patients. - Use lowest effective dose: prescribe the minimal dose needed for symptom control. - Pregnancy caution: avoid use in the third trimester and discuss risks with a healthcare provider. - Concomitant alcohol or NSAID use: limit to reduce gastrointestinal toxicity. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Meloxicam can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Warfarin: increased risk of bleeding. - Other NSAIDs (e.g., ibuprofen, diclofenac): heightened gastrointestinal toxicity. - High‑dose aspirin: additive antiplatelet effect raising bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors (e.g., lisinopril): may reduce antihypertensive effect and impair renal function. - Diuretics (e.g., furosemide): potential for decreased renal clearance. - Lithium: meloxicam may raise lithium serum concentrations, requiring monitoring.